Abstract: This work gives mathematical conditions that guarantee the local stability of the equilibrium regimen of two classes of cell metabolism. In fact, we have analyzed reversible and irreversible linear bacterial metabolic pathways that integrate both genetic and enzymatic control. Moreover, due to these conditions, we can state that: regardless the size of a doubly controlled linear metabolic pathway, the local stability of its steady state depends only on the dynamics of its input and output flux with respect to the concentration of its end product. These results are proved theoretically using some properties of the cooperative matrices.
INTRODUCTION
Stability analysis is recognized as an issue of great importance in order to deduce key properties associated with dynamical models of biological systems. For example, thanks to the stability analysis, we can better understand how the bacteria during the growth phase adapt the concentration of enzymes to ensure that the de novo biosynthesis is sufficients to complete or to fully provide the flux demand for metabolites. Moreover, even though the metabolic network is a complex system, it can be broken down into subsystems with particular control structures which leads bacteria to be able to manage efficiently the control of its metabolic pathways. So, the goal of this work is to analyze the local stability of an end-product control structure, shared by a large number of bacteria and yeasts biosynthesis pathways. In this structure, both genetic and enzymatic controls involve the last product as metabolic effector (Tyson and Othmer, 1978) , (Goelzer et al., 2008) . In the literature, the stability of bacterial metabolic pathways that integrate only the allosteric regulation is well investigated. For instance, one can apply diagonal stability results for cyclic dynamical systems (Arcak and Sontag, 2006) to prove the global stability of the irreversible pathway. As well, one can use some result concerning monotone tridiagonal systems with negative feedback (Wang et al., 2008) , (Wang et al., 2010) to show the global stability of the reversible pathways. However, to the best of our knowledge, stability issue of bacterial metabolic pathways that integrate both genetic and enzymatic control has not been fully studied. In some previous work, we have presented some results about global attractivity of such biological systems (Meslem et al., 2010) . Likewise, recently we have built a Lyapunov function for the irreversible metabolic pathways (Meslem and Fromion, 2011) .
Currently, we attempt to prove the global stability of both irreversible and reversible linear metabolic pathways, under nonrestrictive, easy-to-check conditions. To reach this goal, We will tackle this issue in two stages. The first stage is devoted to improve and to soften the conditions that ensure the global attractivity of the unique equilibrium of linear metabolic pathways given in (Meslem et al., 2010) . In the second stage, we will show the local stability of the globally attractive steady states. Thus, this work is dedicated to accomplish the second stage of this proposed methodology. In fact, we will show that for the type of systems, the local stability of the equilibrum point is guaranteed if the dynamics of the input flux is more important than that of the output flux. This paper is organized as follows. In Section 2, we exhibit realistic models for reversible and irreversible linear bacterial metabolic pathways. Of course, these models highlight both genetic and enzymatic control. The existence and the unicity of equilibrium regimens of these complex biological systems is proved in Section 3. Then, the main findings of this paper about the local stability are stated and proved in section 4.
LINEAR METABOLIC PATHWAYS
As aforementioned in the introduction, here we will study the same end-product control structures in metabolic pathways introduced in (Meslem et al., 2010) . For this reason, we have prefered to keep the same statements and definitions as that given in the previous work with slight modifications.
Let us consider the linear biosynthesis pathways with n metabolites involved in enzymatic reactions with an input flux ν 0 and an output flux ν n as depicted in Figure 1 .
We assume that the pool X 1 of the first metabolite is maintained by the input flux ν 0 which corresponds to a supply flux, hence its concentration x 1 is strictly positive and constant. The output of the pathway is the flux ν n which corresponds to the bacterium requirement for the metabolite X n . In fact, if the cell requires large amounts of X n , the value of ν n will be high and if small amounts of X n are required the value of ν n will be low. Furthermore, as has been experimentally observed and Allosteric and genetic controls Enzymatic reactions Fig. 1 . Linear end-product control structure. X i (i = 1, . . . , n) represent the metabolic pools and E i (i = 1, . . . , n) represent the enzymes that acting in the pathway.
theoretically rationalized (Goelzer et al., 2008) , the end product X n inhibits the first reaction via two control levels: (i) regulation of enzymatic activity and (ii) regulation of enzyme synthesis, herein referred as allosteric control and genetic control respectively. Henceforward, for each i ∈ {2, . . . , n} we denote by x i the nonnegative concentration of the metabolite X i , and by e i we the assumed constant concentration of the enzyme E i . In the literature, the dynamical behavior of the three biochemical phenomena enzymatic reactions, allosteric control and genetic control as presented in Figure 1 is usually modeled by a set of interconnected nonlinear differential equations (Tyson and Othmer, 1978) , (Goelzer et al., 2008) . As aforementioned, the aim of this study is to analyze the local asymptotic stability of the kind of biological systems. Hereafter, nonlinear models for both reversible and irreversible end-product control structure are presented.
Reversible metabolic pathways
Systematic analysis of bacterial metabolic networks shows that almost all reversible pathways have at least one irreversible step and in most cases the irreversible step corresponds to the first enzyme of the pathways. Then, the common end-product control structure of linear reversible metabolic pathways which integrates allosteric and genetic control is described by the following dynamical system:
where the functions f i denote the reaction rates of the enzymes E i . Remember, in this work, we consider that the concentration x 1 of the first metabolite is constant and except for e 1 all other enzyme concentrations are assumed constant. Note that, in this structure, the growth rate functions of all intermediate reactions depend on product and substrate concentration and have the following properties.
• Activity of the first enzyme: it is well-known that the end product X n modulates the activity of the enzyme E 1 through an allosteric effect. So, the function f 1 (x 1 , x n ) is strictly increasing in its first argument and strictly decreasing with respect to its second argument. Moreover, one has for any x 1 > 0, x n ≥ 0 f 1 (x 1 , x n ) > 0 and for any x n ≥ 0, f 1 (0, x n ) = 0. In addition, there exists a constant M 1 > 0 such that for any
and for all x 1 > 0 one has, lim
• Activity of the intermediate enzymes: each reaction rate f i (., .), i ∈ {2, . . . , n − 1}, is strictly increasing in x i and strictly decreasing in x i+1 with the following signs,
. Finally, for any x i > 0 there exists x i+1 > 0 such that f i (x i , x i+1 ) = 0 and for any constant concentration x i+1 , one has lim
• Activity of the final enzyme: E n describes the properties of the remainder parts of the metabolic network which are supplied by the end product X n . Then, the properties of f n mainly depends on the properties of the next modules, and generally f n is a strictly increasing, positive and bounded function in x n such that f n (0) = 0 and lim
where M n is a positive constant. Now, consider the enzyme synthesis phenomenon. It is wellknown that the variation of the first enzyme concentration during the exponential growth phase is mostly the result of two phenomena: (i) the de novo production, and (ii) the dilution effect caused by the increase of the cell volume. The two biochemical observable facts are described by the last differential equation of (1). The continuous, positive and strictly decreasing function g(.) represents the instantaneous production of the enzyme E 1 modulated by the concentration of the end product x n (implicitly through a transcription factor) with, g(0) = g max , where g max > 0 and lim x→+∞ g(x) = 0 and µ is the growth rate of the bacterium assumed to be in the exponential growth phase.
Irreversible metabolic pathways
The main difference between irreversible and reversible endproduct control structure in metabolic pathways is the nature of the reaction rates f i for the intermediate enzymes. Indeed, in the case of irreversible reactions the activities of enzymes depend only on the substrate concentrations and have the following properties:
• Activity of the intermediate enzymes: each reaction rate f i (.), i ∈ {2, . . . , n − 1} is positive and strictly increasing in x i and f i (0) = 0. Moreover, there exists M i > 0 such that lim
Then, one can describe the dynamical behavior of the endproduct control structure in the case of irreversible linear metabolic pathways by the following dynamical system
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After the detailed description of the nonlinear models for both reversible and irreversible linear metabolic pathways that integrate allosteric and genetic control, in the next section we give conditions that guarantee the existence and the uniqueness of equilibrium regimens of the nonlinear dynamical systems (1) and (2).
EXISTENCE AND UNIQUENESS OF STEADY STATES
Let us start our proof by showing the boundedness of the first enzyme concentration e 1 , which is governed by the last differential equation in (1) or in (2). By definition, the function g(.) is positive and bounded, ∀x n ≥ 0, g(x n ) ∈ (0, g max ] Then, we can deduce that for any x n ≥ 0 the time evolution of the first enzyme e 1 (t) is framed betweeň e 1 (t) ≤ e 1 (t) ≤ê 1 (t), whereě 1 (t) andê 1 (t) are respectively the solutions of the following stable first-order linear systemṡ e 1 = −µě 1 , e 1 = −µê 1 + g max . with initial conditionsě 1 (t 0 ) =ê 1 (t 0 ) = e 1 (t 0 ). Consequently, we can conclude that there exists a positive constant e 1 > 0 such that ∀t ≥ 0, e 1 (t) ≤ e 1 .
Once the boundedness of the first enzyme concentration has been proved, the following proposition gives sufficient conditions, which guarantee in the same time the existence of the equilibrium regimen and its uniqueness for both irreversible and reversible linear metabolic pathways (2), (1). Proposition 1. If for each i ∈ {2, . . . , n − 1} the following inequality holds e 1 M 1 < e i M i both irreversible and reversible linear metabolic pathways (2), (1) have a unique equilibrium point.
Proof : First, let us consider the irreversible case. Thus, the nonlinear system (2) reaches an equilibrium regimen if and only if the following set of nonlinear equations are satisfied
So, consider the first equation of (3). It is clear that at the steady state regimen, from this equation we obtain e * 1 = g(x * n ) µ Now consider the second equation of (3). By construction, we know that the left side of this equation is a strictly decreasing function in x n and for x n ∈ [0, +∞) it takes its values in the interval [0, e 1 f 1 (x 1 , 0) ]. On the other hand, the right side of this equation is a strictly increasing function in x n and for x n ∈ [0, +∞) it belongs in the interval [0, M n ). Therefore, we can claim that there exists a unique x * n such that e * 1 f 1 (x 1 , x * n ) = e n f n (x * n ) For the remainder equations of the system (3), we must verify that for each i ∈ {2, . . . , n − 1} there exists a unique x * i such that e i f i (x * i ) = e * 1 f 1 (x 1 , x * n ) Since the functions f i (.) are strictly increasing in x i and bounded with known bound M i , the above equation is satisfied for all i ∈ {2, . . . , n − 1} if e 1 M 1 < e i M i This completes the proof of Proposition 1 in the case of irreversible linear metabolic pathways (2). Now, let us consider the case of reversible metabolic pathways. The equilibrium conditions of the nonlinear system (1) are given by the following set of nonlinear equations
Note that, the first and the second equation of the above set of nonlinear equations (4) are the same as in the case of irreversible pathways. Then, we can claim that, each of these two equations has a unique solution x * n and e * 1 respectively. That means, by definition there exists a unique value x * n such that
Now consider the third equation of (4), namely e n−1 f n−1 (x n−1 , x * n ) = e * 1 f 1 (x 1 , x * n ) We know that, by construction, the function f n−1 (., .) is strictly increasing in x n−1 and for any x n * ∈ [0, +∞) we get lim
Thus, according to these properties, we can claim that if the following inequality holds e 1 M 1 < e n−1 M n−1 then there exists a unique solution x * n−1 for the third equation of (4). In the same way, since the functions f i (., .) have the same properties, we can state that the following inequalities e 1 M 1 < e i M i i = 2, . . . , n − 2 guarantee both existence and uniqueness of equilibrium points x * i for the remainder equations of (4). This completes the proof of Proposition 1.
LOCAL STABILITY
In this section, we state and prove the main contribution of this study concerning the local stability of the equilibrium regimens of both reversible and irreversible linear metabolic pathways (1), (2). Proposition 2. Denote by f 1 , f n and g the derivatives of the functions f 1 , f n and g with respect to x n . Then, if the inequality is satisfied 
That is, the local stability of these biological systems is guaranteed if the dynamics of the input flux with respect to the concentration of the end product is strictly greater than the dynamics of the output flux with respect to the concentration of the same metabolite.
The next subsections are devoted to give the proof of Proposition 2.
Proof of Proposition 2 (irreversible case)
First, denote by A the Jacobian matrix of the nonlinear system (2) evaluated at its equilibrium point, 
where each f i represents the derivative of the function f i with respect to x i computed for x i = x * i . Recall that, by definition, except f 1 and g which are negative all the derivatives f i are positive. Then, according to the monotonicity of the functions f i (.) with respect to their arguments x i , we can easily determine from the matrix A a cooperative matrix C . In fact, to obtain C we just substitute in A the negative entries f 1 and g by their absolute values. 
Now, consider the linearized system (7) of the nonlinear system (2), δẏ = Aδ y (7) where δ y i = x i − x * i for i = 2, . . . n and δ y n+1 = e 1 − e * 1 . Then, according to the Lemma 16 of (Wang et al., 2010) or by using the well known properties of nonnegative matrices gathered in (Berman and Plemmons, 1994) , we can state that the origin (δ y = 0) of the linearized system is asymptotically stable if there exist two positive componentwise vectors D and B such that C D ≤ −B (8) which is equivalent to say that there exists a positive componentwise vector D such that −C D > 0 (9) In (8) and (9), the order relations (≤, >) must be understood component by component. Thus, to prove Proposition 2 in the case of irreversible metabolic pathways, it is enough to check (9). That means, we will show that there exists a positive vector (9) is true. To do so, let us start from the last element of the vector −C D. Hence, we must choose positive constants d n and d n−1 such that µd n > |g |d n−1 Then, for a given d n we must take
For the next element of the vector −C D, we should choose a positive constant d n−2 such that e n f n d n−1 > e n−1 f n−1 d n−2 which is equivalent to d n−2 < e n f n e n−1 f n−1 d n−1
Thus, we iterate this procedure from the (n − 2)th element of the vector −C D until its 2nd element to obtain the following conditions on the entries of the positive vector D
Moreover, the first element of vector −C D must satisfy
Furthermore, taking into account (10), the latter equation is true if
Then, from (12) and (13) d 1 must satisfy the following double inequalities 1 e 2 f 2
By direct computation, we can show that the above double inequalities (14) is always satisfied if and only if
Thus, there exists d 1 satisfying (14). In the same manner, we can show that for i = 2, . . . , n − 2, there exists d i belonging to the following interval 1 e i+1 f i+1
if and only if
Hence, the last condition implies that
and according to (10), d n−1 must satisfy the following double inequalities 1 e n f n
Then, by direct computation we can easily show that (19) is satisfied if CAB 2013 December 16-18, 2013 which is exactly the condition (5) of Proposition 2. That means, if (5) holds then there exists a positive componentwise vector D for that (9) is true. This completes the proof of Proposition 2 in the case of irreversible metabolic pathways. In the next subsection, we will prove Proposition 2 for the reversible case.
Proof of Proposition 2 (reversible case)
Let us consider the Jacobian matrix A of the nonlinear system (1) evaluated at its equilibrium point. By direct computation we get 
where each f i, j represents the partial derivative of the function f i (., .) with respect to the argument x j computed for x i = x * i and x j = x * j . Note that, by definition, the partial derivatives f ii are strictly positive and for i = j the partial derivatives f i j are strictly negative. Then, from the Jacobian matrix A we build the following cooperative matrix 
Thus, as in the case of irreversible metabolic pathways, the local stability of the nonlinear system (1) is guaranteed if the condition (9) holds. Then, let us show that under (5) this condition is fulfilled.
For the last element of the vector −C D, we should choose positive constants d n and d n−1 such that µd n > |g |d n−1 This implies that for a given d n we must take
Then, for the next element of the vector −C D, the positive constant d n−2 must satisfy (e n f n − e n−1 f (n−1)n )d n−1 > e n−1 f (n−1)(n−1) d n−2
That is, d n−2 < e n f n − e n−1 f (n−1)n e n−1 f (n−1)(n−1)
In the same way, the (n − 2)th element of the vector −C D must satisfy the following inequality
Moreover, d n−3 must be positive. Then, to guarantee this condition on d n−3 we should choose d n−2 such that e n−1 f (n−1)(n−1) − e n−2 f (n−2)(n−1) d n−2 + e (n−1) f (n−1)n )d n−1 > 0 Moreover, d 1 has to be lower than (27) . By direct computation, we can show that this condition on d 1 is satisfied if
Following this reasoning, we can show that for all i = 1, . . . , n − 3 the double inequalities defined by (28) and (27) are satisfied if
In other hand d n−2 must be lower than (21). Thus, by direct computation, we can show that this condition is fulfilled if
Finally, according to the condition (20) we should have
So, it is clear that to ensure this inequality the following condition must be true µ > |g | f 1 e n f n − e 1 | f 1n | which is exactly the condition (5) Before to conclude, note that one can easily extend the use of Proposition 1 and Proposition 2 to analyse the local stability of more complicated end-product control structures. For instance, one can apply these propositions to study the case of endproduct control structures where all the enzyme concentrations e i , i = 1, . . . , n are considered variable in time but bounded with known bounds and also the case where the intermediate enzymatic reactions are mixed. That is, metabolic pathways where some enzymatic reactions are reversible and some other ones are irrreversible. For example, the case of the metabolic pathway of Tryptophan synthesis (Goelzer et al., 2008) .
CONCLUSION
This work proposed mathematical conditions to check the local stability of linear reversible and irreversible metabolic pathways. Moreover, thanks to these conditions, we can claim that regardless of the size of these linear metabolic pathways, only dynamical properties of the activity of the first enzyme can guarantee the local stability of their steady state. This shows the natural capacity of bacteria to cope with increasing of their flux demand by activating only the first enzyme of their metabolic pathway. As well, the mathematical property of the end-product control structure helps to simplify the behavior analysis of complex metabolic pathways and to predict the changes of their components (enzyme concentrations, metabolite pools and fluxes). Furthermore, a comparative analysis between the mathematical predicted behavior and biological data may help to detect still undescribed regulations in a systematic way. In fact, unknown regulations can be highlighted by discrepancies. Indeed, in practice, the bacterium always adapts the flux capacity provided by the pathway to satisfy the flux demand and may employ other mechanisms to cope with the flux demand in some situations. Such mechanisms may modify enzyme activity, enzyme production or flux capacity.
For forthcoming work we will use the local stability result to prove the global stability of both reversible and irreversible linear metabolic pathway. In fact, to do so, we will simplify our global attractivity conditions presented in (Meslem et al., 2010) and then we will show that the local stability condition given in this paper allied with the global attractivity conditions guarantee the global stability of the end-product control structures. Also, in order to show the merits of this theoretical work, we will compare our mathematical findings to real world problems. For instance, we plan to use measurement data coming from the Tryptophan or Lysine synthesis to validate our theoretical prediction concerning the stability of these types of end-product control structures.
